BioSpace News Archive

Renibus is a clinical stage biopharmaceutical company dedicated to treating, improving and extending patients’ lives by developing breakthrough products to prevent disease progression, improve outcomes and protect against organ damage in cardiorenal diseases.

POINT Biopharma develops next-generation radioligand therapies for the treatment of cancer

MAIA Biotechnology is a targeted therapy, immune-oncology company, focused on development and commercialization of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer.

ScitoVation is a contract research organization providing clients with the science, technical expertise and technology to understand how chemical compounds and drugs affect human health.

Catawba Research is a full-service Global contract research organization (CRO) providing clinical management services to pharmaceutical, device, formulation development and biotechnology companies.

Tiamat Sciences is a plant-based platform and product life sciences company that is revolutionizing the production of reagents for the pharmaceutical industry.

Gemelli Biotech leverages leading biological discoveries related to the microbiome to provide non-invasive precision diagnostics which enable clinicians to definitively detect scientifically validated biomarkers and optimally treat GI diseases including SIBO, IMO, excess hydrogen sulfide and post-infectious IBS.

Clinical ink is the global life science company that brings data, technology, and patient-centric research together.

Outpace is creating cell therapies with curative potential through protein design and cellular engineering. With an initial focus on solid tumors, Outpace is developing technologies that overcome the barriers to efficacy and safety by programming cells to make the right decisions inside patients.

Monod Bio is a pioneer company in the design of de novo protein biosensors. Our innovative biosensor platform technology takes advantage of the most recent advances in computational protein engineering to create highly modular biosensing nanoswitches that enable rapid, sensitive, and inexpensive analytical assays.